Objective: Small volume prostate cancers (0.10 ng/ml. Results: In the total group, the median age at the time Of Surgery was 62.7 years (42.4-73.4) and the median preoperative PSA level was 8.0 ng/ml. Patients with InsigPC had Gleason scores of 4 in 7%, 5 in 37%, and 6 in 56%. Positive surgical margins were identified in 13 (15.9%) svPC and in 8 (12.7%) InsigPC specimens. The 5-year risk of BCR for the svPC group and the insigPC group was 10% (95% Cl 2-18%, 7 and 5 patients, respectively) vs. 35% (95% CI 29-41%) in the rest of the cohort (log rank P = 0.001). Conclusion: Patients with svPC and patients with InsigPC have a significantly lower risk of BCR. However, even in this seemingly very favorable patient group, I in 10 patients will develop a BCR after RP. Therefore, new studies are needed to examine what the prognostic relevance is of small-volume tumors. (C) 2009 Elsevier Inc. All rights reserved.
|Journal||Urology Oncology: Seminars and Original Investigations|
|Publication status||Published - 2009|
- retropubic prostatectomy
- independent predictor